dc.creatorMuñoz, Lorena [Univ Mayor, Fac Med, Med, Camino La Piramide 5750, Huechuraba 8580745, Santiago De, Chile]
dc.creatorMurray, Nigel P.
dc.creatorMinzer, Simona
dc.creatorAntonio López, Marco
dc.date.accessioned2020-04-08T14:11:55Z
dc.date.accessioned2020-04-13T18:12:50Z
dc.date.accessioned2022-10-18T18:41:01Z
dc.date.available2020-04-08T14:11:55Z
dc.date.available2020-04-13T18:12:50Z
dc.date.available2022-10-18T18:41:01Z
dc.date.created2020-04-08T14:11:55Z
dc.date.created2020-04-13T18:12:50Z
dc.date.issued2018
dc.identifierMurray, N. P., Muñoz, L., Minzer, S., & Lopez, M. A. (2018). Management of thrombosis risk in a carrier of hemophilia a with low factor VIII levels with atrial fibrillation: a clinical case and literature review. Case reports in hematology, 2018.
dc.identifier2090-6560
dc.identifier2090-6579
dc.identifierhttps://doi.org/10.1155/2018/2615838
dc.identifierhttp://repositorio.umayor.cl/xmlui/handle/sibum/6245
dc.identifierDOI: 10.1155/2018/2615838
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4454088
dc.description.abstractNonvalvular atrial fibrillation (AF) is a common age-related arrthymia and a leading cause of stroke in the elderly; with an aging hemophilia population, the number of patients developing AF is increasing. There are no controlled trials on thromboprophylaxis in this group of patients, only consensus opinion was based on small case reports. We present a female patient, carrier for hemophilia and with clinically moderately severe hemophilia who developed FA. We discuss the literature with respect to this group of patients and current recommendations for thromboprophylaxis.
dc.languageen
dc.publisherHINDAWI LTD
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceCase Rep. Hematol., 2018.
dc.subjectHematology
dc.titleManagement of Thrombosis Risk in a Carrier of Hemophilia A with Low Factor VIII Levels with Atrial Fibrillation: A Clinical Case and Literature Review
dc.typeOtros


Este ítem pertenece a la siguiente institución